Michael Beeuwsaert, President & CEO

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Mr. Beeuwsaert has over 20 years of health care experience with firms ranging from Fortune 500 to start-ups. Prior to forming Numira, he served from April 2002 to November 2005 as President & CEO of Alerion Biomedical Inc., a company developing several imaging agent technologies for clinical and pre-clinical applications. He led the company through the commercialization of imaging agents for the pharmaceutical and academic research markets.

From August 1996 to April 2001, Mr. Beeuwsaert held executive management positions at LXN Corporation, initially as the CFO, and then President and CEO. LXN, a medical device company, developed innovative measuring devices for the control of diabetes. He led the company through the successful commercialization of three 510(k) approved devices for both physicians and patients, establishing multiple channels of professional and retail distribution, reimbursement, and market acceptance. After filing a registration statement for an IPO, he led the Company to a successful sale to an industry leader.

Mr. Beeuwsaert received a BA in Accounting from California State University, Fullerton and a MBA from Pepperdine University.

 

David Weinstein, Ph.D., Chief Technology Officer

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Dr. Weinstein has over 10 years of experience in software development, image processing, and managing the development of software systems for medical imaging.

Prior to the acquisition by Numira, he was the President and Chief Technology Officer for Visual Influence, Inc., a company formed in 2001 to focus primarily on exporting technology from the University of Utah’s Scientific Computing and Imaging Institute to commercial applications.  As the President and CTO of Visual Influence, Dr. Weinstein set the overall direction for the company, sought out and fostered new project opportunities, managed project development for all Visual Influence contracts, and directed day-to-day operations.

Dr. Weinstein is also a technical manager for the NIH NCRR Center for Integrative Biomedical Computing, within the Scientific Computing and Imaging Institute at the University of Utah. As a Technical Manager, Dr. Weinstein assists in defining and communicating the Center’s direction, develops collaborative research projects, and coordinates the Center’s software development efforts to meet the needs of the biomedical community.

Dr. Weinstein received his Ph.D. in computer science from the University of Utah and B.S. degrees in computer science and mathematics from U.C. Berkeley.

Stacey Gavigan, Director of Sales & Marketing

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Stacey has 15 years of experience in the scientific community.  Her diverse life science experience is both highly technical and customer centric.  It is comprised of hands on research in both the academic and pharmaceutical arenas, customer support with laboratory automation and instrumentation, and Sales Account Management.

Prior to joining Numira, she held various sales positions at PerkinElmer Life and Analytical Sciences.  She was responsible for the Southern California territory handling academic, biotech and clinical diagnostic accounts.  During her tenure with PerkinElmer she successfully expanded the HTS revenue base and launched several new products within her territory.  Prior to joining Perkin Elmer, she was a Senior Research professional at Allergan in the molecular biology group.  Stacey graduated from the George Washington University with a BS in Zoology.

 

Brad Johnston, Director of Operations

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Mr. Johnston has over 10 years of laboratory management and operations experience in both industry and academic settings.

Prior to joining Numira, he was in project management at Tandem Labs, a leading bioanalytical contract research organization (CRO). During this time he was responsible for all aspects of client projects including compliance with applicable regulatory requirements, deadlines and revenue targets.  He was the Manager of the Analytical Department at MacroMed, Inc. (since acquired by Protherics-BTG), where he was responsible for the daily operations of the department as well as establishing the GMP compliant QC department.  Before this he was involved in laboratory research  and management in various academic institutions overseeing multiple programs.

Mr. Johnston received a B.S. in Biology from the University of Wyoming and  M.S. in Zoology from Idaho State University.

 

Daniel Small, Ph.D., Vice President, Scientific & Business Development

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Dr. Small has 19 years of experience in pre-clinical drug development with more than 60 publications including seven book chapters in the area of neuroscience.

Prior to the acquisition by Numira, he was Sr. Director of Bothell Operations for Ricerca Biosciences (formerly MDS Pharma Services), a pre-clinical global CRO with more than 1,300 assays and models from medicinal chemistry to toxicology. He was responsible for two 40,000 sf facilities including a GLP vivarium, a histology lab and a robotics lab. He was responsible for all aspects of the operation, including P&L, quality assurance, facilities, technical sales, and health and safety.

Prior to joining MDS Pharma Services he spent five years as a senior manager at Lexicon Pharmaceuticals, Texas. There, Dr. Small participated in screening more than 3000 unique transgenic mouse lines using behavioral and biological assays focusing on the therapeutic areas of pain, schizophrenia, anxiety, depression, neurodegeneration, neurogenesis, and cognition. Prior to joining Lexicon Pharmaceuticals, he was an Adjunct Professor at the University of Ottawa, and Research Officer at the National Research Council of Canada where he ran a stroke research lab.

Dr. Small received his Ph.D. in biology and M.Sc. in physiology from the University of Ottawa and his B.Sc. in zoology from the University of Toronto.